Global Non-Adhesive Liquid Embolic Agents Market Growth 2026-2032
The global Non-Adhesive Liquid Embolic Agents market size is predicted to grow from US$ 149 million in 2025 to US$ 252 million in 2032; it is expected to grow at a CAGR of 7.9% from 2026 to 2032.
Non-adhesive liquid embolic agents are a type of medical substance used in interventional procedures, particularly in endovascular embolization treatments, to block blood vessels. Unlike traditional adhesive embolic agents, which rely on chemical bonding to vessel walls, non-adhesive liquid embolics do not adhere to tissue but instead occlude blood flow by physically plugging the vessel lumen. These agents are typically delivered through a catheter and are designed to solidify or gel after being injected, forming a stable mass that prevents further blood flow. They are often used for treating conditions like arteriovenous malformations (AVMs), tumors, or aneurysms, where precise occlusion of abnormal blood vessels is required.
United States market for Non-Adhesive Liquid Embolic Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Non-Adhesive Liquid Embolic Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Non-Adhesive Liquid Embolic Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Non-Adhesive Liquid Embolic Agents players cover Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Non-Adhesive Liquid Embolic Agents Industry Forecast? looks at past sales and reviews total world Non-Adhesive Liquid Embolic Agents sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-Adhesive Liquid Embolic Agents sales for 2026 through 2032. With Non-Adhesive Liquid Embolic Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Adhesive Liquid Embolic Agents industry.
This Insight Report provides a comprehensive analysis of the global Non-Adhesive Liquid Embolic Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Adhesive Liquid Embolic Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-Adhesive Liquid Embolic Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Adhesive Liquid Embolic Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Adhesive Liquid Embolic Agents.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Adhesive Liquid Embolic Agents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Non-Adhesive Liquid Embolic Agents market?
What factors are driving Non-Adhesive Liquid Embolic Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-Adhesive Liquid Embolic Agents market opportunities vary by end market size?
How does Non-Adhesive Liquid Embolic Agents break out by Type, by Application?
Non-adhesive liquid embolic agents are a type of medical substance used in interventional procedures, particularly in endovascular embolization treatments, to block blood vessels. Unlike traditional adhesive embolic agents, which rely on chemical bonding to vessel walls, non-adhesive liquid embolics do not adhere to tissue but instead occlude blood flow by physically plugging the vessel lumen. These agents are typically delivered through a catheter and are designed to solidify or gel after being injected, forming a stable mass that prevents further blood flow. They are often used for treating conditions like arteriovenous malformations (AVMs), tumors, or aneurysms, where precise occlusion of abnormal blood vessels is required.
United States market for Non-Adhesive Liquid Embolic Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Non-Adhesive Liquid Embolic Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Non-Adhesive Liquid Embolic Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Non-Adhesive Liquid Embolic Agents players cover Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Non-Adhesive Liquid Embolic Agents Industry Forecast? looks at past sales and reviews total world Non-Adhesive Liquid Embolic Agents sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-Adhesive Liquid Embolic Agents sales for 2026 through 2032. With Non-Adhesive Liquid Embolic Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Adhesive Liquid Embolic Agents industry.
This Insight Report provides a comprehensive analysis of the global Non-Adhesive Liquid Embolic Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Adhesive Liquid Embolic Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-Adhesive Liquid Embolic Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Adhesive Liquid Embolic Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Adhesive Liquid Embolic Agents.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Adhesive Liquid Embolic Agents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- EVOH-Based
- Diluted Cyanoacrylate
- Others
- Brain Arterio-Venous Malformations (bAVM)
- Tumor Embolization
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Balt Group
- Johnson & Johnson
- Meril Life
- BlackSwan Vascular
- Success Bio-Tech
What is the 10-year outlook for the global Non-Adhesive Liquid Embolic Agents market?
What factors are driving Non-Adhesive Liquid Embolic Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-Adhesive Liquid Embolic Agents market opportunities vary by end market size?
How does Non-Adhesive Liquid Embolic Agents break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Adhesive Liquid Embolic Agents Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Non-Adhesive Liquid Embolic Agents by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Non-Adhesive Liquid Embolic Agents by Country/Region, 2021, 2025 & 2032
2.2 Non-Adhesive Liquid Embolic Agents Segment by Type
2.2.1 EVOH-Based
2.2.2 Diluted Cyanoacrylate
2.2.3 Others
2.2.4 Non-Adhesive Liquid Embolic Agents Sales by Type
2.2.4.1 Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2021-2026)
2.2.4.2 Global Non-Adhesive Liquid Embolic Agents Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Non-Adhesive Liquid Embolic Agents Sale Price by Type (2021-2026)
2.3 Non-Adhesive Liquid Embolic Agents Segment by Application
2.3.1 Brain Arterio-Venous Malformations (bAVM)
2.3.2 Tumor Embolization
2.3.3 Others
2.3.4 Non-Adhesive Liquid Embolic Agents Sales by Application
2.3.4.1 Global Non-Adhesive Liquid Embolic Agents Sale Market Share by Application (2021-2026)
2.3.4.2 Global Non-Adhesive Liquid Embolic Agents Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Non-Adhesive Liquid Embolic Agents Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Non-Adhesive Liquid Embolic Agents Breakdown Data by Company
3.1.1 Global Non-Adhesive Liquid Embolic Agents Annual Sales by Company (2021-2026)
3.1.2 Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Company (2021-2026)
3.2 Global Non-Adhesive Liquid Embolic Agents Annual Revenue by Company (2021-2026)
3.2.1 Global Non-Adhesive Liquid Embolic Agents Revenue by Company (2021-2026)
3.2.2 Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Company (2021-2026)
3.3 Global Non-Adhesive Liquid Embolic Agents Sale Price by Company
3.4 Key Manufacturers Non-Adhesive Liquid Embolic Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-Adhesive Liquid Embolic Agents Product Location Distribution
3.4.2 Players Non-Adhesive Liquid Embolic Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-ADHESIVE LIQUID EMBOLIC AGENTS BY GEOGRAPHIC REGION
4.1 World Historic Non-Adhesive Liquid Embolic Agents Market Size by Geographic Region (2021-2026)
4.1.1 Global Non-Adhesive Liquid Embolic Agents Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Non-Adhesive Liquid Embolic Agents Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Non-Adhesive Liquid Embolic Agents Market Size by Country/Region (2021-2026)
4.2.1 Global Non-Adhesive Liquid Embolic Agents Annual Sales by Country/Region (2021-2026)
4.2.2 Global Non-Adhesive Liquid Embolic Agents Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-Adhesive Liquid Embolic Agents Sales Growth
4.4 APAC Non-Adhesive Liquid Embolic Agents Sales Growth
4.5 Europe Non-Adhesive Liquid Embolic Agents Sales Growth
4.6 Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales Growth
5 AMERICAS
5.1 Americas Non-Adhesive Liquid Embolic Agents Sales by Country
5.1.1 Americas Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026)
5.1.2 Americas Non-Adhesive Liquid Embolic Agents Revenue by Country (2021-2026)
5.2 Americas Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026)
5.3 Americas Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Adhesive Liquid Embolic Agents Sales by Region
6.1.1 APAC Non-Adhesive Liquid Embolic Agents Sales by Region (2021-2026)
6.1.2 APAC Non-Adhesive Liquid Embolic Agents Revenue by Region (2021-2026)
6.2 APAC Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026)
6.3 APAC Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-Adhesive Liquid Embolic Agents by Country
7.1.1 Europe Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026)
7.1.2 Europe Non-Adhesive Liquid Embolic Agents Revenue by Country (2021-2026)
7.2 Europe Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026)
7.3 Europe Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Adhesive Liquid Embolic Agents by Country
8.1.1 Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026)
8.1.2 Middle East & Africa Non-Adhesive Liquid Embolic Agents Revenue by Country (2021-2026)
8.2 Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026)
8.3 Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-Adhesive Liquid Embolic Agents
10.3 Manufacturing Process Analysis of Non-Adhesive Liquid Embolic Agents
10.4 Industry Chain Structure of Non-Adhesive Liquid Embolic Agents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-Adhesive Liquid Embolic Agents Distributors
11.3 Non-Adhesive Liquid Embolic Agents Customer
12 WORLD FORECAST REVIEW FOR NON-ADHESIVE LIQUID EMBOLIC AGENTS BY GEOGRAPHIC REGION
12.1 Global Non-Adhesive Liquid Embolic Agents Market Size Forecast by Region
12.1.1 Global Non-Adhesive Liquid Embolic Agents Forecast by Region (2027-2032)
12.1.2 Global Non-Adhesive Liquid Embolic Agents Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Non-Adhesive Liquid Embolic Agents Forecast by Type (2027-2032)
12.7 Global Non-Adhesive Liquid Embolic Agents Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
13.1.3 Medtronic Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Balt Group
13.2.1 Balt Group Company Information
13.2.2 Balt Group Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
13.2.3 Balt Group Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Balt Group Main Business Overview
13.2.5 Balt Group Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
13.3.3 Johnson & Johnson Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Meril Life
13.4.1 Meril Life Company Information
13.4.2 Meril Life Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
13.4.3 Meril Life Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Meril Life Main Business Overview
13.4.5 Meril Life Latest Developments
13.5 BlackSwan Vascular
13.5.1 BlackSwan Vascular Company Information
13.5.2 BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
13.5.3 BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 BlackSwan Vascular Main Business Overview
13.5.5 BlackSwan Vascular Latest Developments
13.6 Success Bio-Tech
13.6.1 Success Bio-Tech Company Information
13.6.2 Success Bio-Tech Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
13.6.3 Success Bio-Tech Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Success Bio-Tech Main Business Overview
13.6.5 Success Bio-Tech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Adhesive Liquid Embolic Agents Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Non-Adhesive Liquid Embolic Agents by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Non-Adhesive Liquid Embolic Agents by Country/Region, 2021, 2025 & 2032
2.2 Non-Adhesive Liquid Embolic Agents Segment by Type
2.2.1 EVOH-Based
2.2.2 Diluted Cyanoacrylate
2.2.3 Others
2.2.4 Non-Adhesive Liquid Embolic Agents Sales by Type
2.2.4.1 Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2021-2026)
2.2.4.2 Global Non-Adhesive Liquid Embolic Agents Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Non-Adhesive Liquid Embolic Agents Sale Price by Type (2021-2026)
2.3 Non-Adhesive Liquid Embolic Agents Segment by Application
2.3.1 Brain Arterio-Venous Malformations (bAVM)
2.3.2 Tumor Embolization
2.3.3 Others
2.3.4 Non-Adhesive Liquid Embolic Agents Sales by Application
2.3.4.1 Global Non-Adhesive Liquid Embolic Agents Sale Market Share by Application (2021-2026)
2.3.4.2 Global Non-Adhesive Liquid Embolic Agents Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Non-Adhesive Liquid Embolic Agents Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Non-Adhesive Liquid Embolic Agents Breakdown Data by Company
3.1.1 Global Non-Adhesive Liquid Embolic Agents Annual Sales by Company (2021-2026)
3.1.2 Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Company (2021-2026)
3.2 Global Non-Adhesive Liquid Embolic Agents Annual Revenue by Company (2021-2026)
3.2.1 Global Non-Adhesive Liquid Embolic Agents Revenue by Company (2021-2026)
3.2.2 Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Company (2021-2026)
3.3 Global Non-Adhesive Liquid Embolic Agents Sale Price by Company
3.4 Key Manufacturers Non-Adhesive Liquid Embolic Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-Adhesive Liquid Embolic Agents Product Location Distribution
3.4.2 Players Non-Adhesive Liquid Embolic Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-ADHESIVE LIQUID EMBOLIC AGENTS BY GEOGRAPHIC REGION
4.1 World Historic Non-Adhesive Liquid Embolic Agents Market Size by Geographic Region (2021-2026)
4.1.1 Global Non-Adhesive Liquid Embolic Agents Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Non-Adhesive Liquid Embolic Agents Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Non-Adhesive Liquid Embolic Agents Market Size by Country/Region (2021-2026)
4.2.1 Global Non-Adhesive Liquid Embolic Agents Annual Sales by Country/Region (2021-2026)
4.2.2 Global Non-Adhesive Liquid Embolic Agents Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-Adhesive Liquid Embolic Agents Sales Growth
4.4 APAC Non-Adhesive Liquid Embolic Agents Sales Growth
4.5 Europe Non-Adhesive Liquid Embolic Agents Sales Growth
4.6 Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales Growth
5 AMERICAS
5.1 Americas Non-Adhesive Liquid Embolic Agents Sales by Country
5.1.1 Americas Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026)
5.1.2 Americas Non-Adhesive Liquid Embolic Agents Revenue by Country (2021-2026)
5.2 Americas Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026)
5.3 Americas Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Adhesive Liquid Embolic Agents Sales by Region
6.1.1 APAC Non-Adhesive Liquid Embolic Agents Sales by Region (2021-2026)
6.1.2 APAC Non-Adhesive Liquid Embolic Agents Revenue by Region (2021-2026)
6.2 APAC Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026)
6.3 APAC Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-Adhesive Liquid Embolic Agents by Country
7.1.1 Europe Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026)
7.1.2 Europe Non-Adhesive Liquid Embolic Agents Revenue by Country (2021-2026)
7.2 Europe Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026)
7.3 Europe Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Adhesive Liquid Embolic Agents by Country
8.1.1 Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026)
8.1.2 Middle East & Africa Non-Adhesive Liquid Embolic Agents Revenue by Country (2021-2026)
8.2 Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026)
8.3 Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-Adhesive Liquid Embolic Agents
10.3 Manufacturing Process Analysis of Non-Adhesive Liquid Embolic Agents
10.4 Industry Chain Structure of Non-Adhesive Liquid Embolic Agents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-Adhesive Liquid Embolic Agents Distributors
11.3 Non-Adhesive Liquid Embolic Agents Customer
12 WORLD FORECAST REVIEW FOR NON-ADHESIVE LIQUID EMBOLIC AGENTS BY GEOGRAPHIC REGION
12.1 Global Non-Adhesive Liquid Embolic Agents Market Size Forecast by Region
12.1.1 Global Non-Adhesive Liquid Embolic Agents Forecast by Region (2027-2032)
12.1.2 Global Non-Adhesive Liquid Embolic Agents Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Non-Adhesive Liquid Embolic Agents Forecast by Type (2027-2032)
12.7 Global Non-Adhesive Liquid Embolic Agents Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
13.1.3 Medtronic Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Balt Group
13.2.1 Balt Group Company Information
13.2.2 Balt Group Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
13.2.3 Balt Group Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Balt Group Main Business Overview
13.2.5 Balt Group Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
13.3.3 Johnson & Johnson Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Meril Life
13.4.1 Meril Life Company Information
13.4.2 Meril Life Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
13.4.3 Meril Life Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Meril Life Main Business Overview
13.4.5 Meril Life Latest Developments
13.5 BlackSwan Vascular
13.5.1 BlackSwan Vascular Company Information
13.5.2 BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
13.5.3 BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 BlackSwan Vascular Main Business Overview
13.5.5 BlackSwan Vascular Latest Developments
13.6 Success Bio-Tech
13.6.1 Success Bio-Tech Company Information
13.6.2 Success Bio-Tech Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
13.6.3 Success Bio-Tech Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Success Bio-Tech Main Business Overview
13.6.5 Success Bio-Tech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-Adhesive Liquid Embolic Agents Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Non-Adhesive Liquid Embolic Agents Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of EVOH-Based
Table 4. Major Players of Diluted Cyanoacrylate
Table 5. Major Players of Others
Table 6. Global Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026) & (K Dose)
Table 7. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2021-2026)
Table 8. Global Non-Adhesive Liquid Embolic Agents Revenue by Type (2021-2026) & ($ million)
Table 9. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Type (2021-2026)
Table 10. Global Non-Adhesive Liquid Embolic Agents Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Global Non-Adhesive Liquid Embolic Agents Sale by Application (2021-2026) & (K Dose)
Table 12. Global Non-Adhesive Liquid Embolic Agents Sale Market Share by Application (2021-2026)
Table 13. Global Non-Adhesive Liquid Embolic Agents Revenue by Application (2021-2026) & ($ million)
Table 14. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Application (2021-2026)
Table 15. Global Non-Adhesive Liquid Embolic Agents Sale Price by Application (2021-2026) & (US$/Dose)
Table 16. Global Non-Adhesive Liquid Embolic Agents Sales by Company (2021-2026) & (K Dose)
Table 17. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Company (2021-2026)
Table 18. Global Non-Adhesive Liquid Embolic Agents Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Company (2021-2026)
Table 20. Global Non-Adhesive Liquid Embolic Agents Sale Price by Company (2021-2026) & (US$/Dose)
Table 21. Key Manufacturers Non-Adhesive Liquid Embolic Agents Producing Area Distribution and Sales Area
Table 22. Players Non-Adhesive Liquid Embolic Agents Products Offered
Table 23. Non-Adhesive Liquid Embolic Agents Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Non-Adhesive Liquid Embolic Agents Sales by Geographic Region (2021-2026) & (K Dose)
Table 27. Global Non-Adhesive Liquid Embolic Agents Sales Market Share Geographic Region (2021-2026)
Table 28. Global Non-Adhesive Liquid Embolic Agents Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Non-Adhesive Liquid Embolic Agents Sales by Country/Region (2021-2026) & (K Dose)
Table 31. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Country/Region (2021-2026)
Table 32. Global Non-Adhesive Liquid Embolic Agents Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026) & (K Dose)
Table 35. Americas Non-Adhesive Liquid Embolic Agents Sales Market Share by Country (2021-2026)
Table 36. Americas Non-Adhesive Liquid Embolic Agents Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026) & (K Dose)
Table 38. Americas Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026) & (K Dose)
Table 39. APAC Non-Adhesive Liquid Embolic Agents Sales by Region (2021-2026) & (K Dose)
Table 40. APAC Non-Adhesive Liquid Embolic Agents Sales Market Share by Region (2021-2026)
Table 41. APAC Non-Adhesive Liquid Embolic Agents Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026) & (K Dose)
Table 43. APAC Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026) & (K Dose)
Table 44. Europe Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026) & (K Dose)
Table 45. Europe Non-Adhesive Liquid Embolic Agents Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026) & (K Dose)
Table 47. Europe Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026) & (K Dose)
Table 48. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026) & (K Dose)
Table 49. Middle East & Africa Non-Adhesive Liquid Embolic Agents Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026) & (K Dose)
Table 51. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026) & (K Dose)
Table 52. Key Market Drivers & Growth Opportunities of Non-Adhesive Liquid Embolic Agents
Table 53. Key Market Challenges & Risks of Non-Adhesive Liquid Embolic Agents
Table 54. Key Industry Trends of Non-Adhesive Liquid Embolic Agents
Table 55. Non-Adhesive Liquid Embolic Agents Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Non-Adhesive Liquid Embolic Agents Distributors List
Table 58. Non-Adhesive Liquid Embolic Agents Customer List
Table 59. Global Non-Adhesive Liquid Embolic Agents Sales Forecast by Region (2027-2032) & (K Dose)
Table 60. Global Non-Adhesive Liquid Embolic Agents Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Non-Adhesive Liquid Embolic Agents Sales Forecast by Country (2027-2032) & (K Dose)
Table 62. Americas Non-Adhesive Liquid Embolic Agents Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Non-Adhesive Liquid Embolic Agents Sales Forecast by Region (2027-2032) & (K Dose)
Table 64. APAC Non-Adhesive Liquid Embolic Agents Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Non-Adhesive Liquid Embolic Agents Sales Forecast by Country (2027-2032) & (K Dose)
Table 66. Europe Non-Adhesive Liquid Embolic Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales Forecast by Country (2027-2032) & (K Dose)
Table 68. Middle East & Africa Non-Adhesive Liquid Embolic Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Non-Adhesive Liquid Embolic Agents Sales Forecast by Type (2027-2032) & (K Dose)
Table 70. Global Non-Adhesive Liquid Embolic Agents Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Non-Adhesive Liquid Embolic Agents Sales Forecast by Application (2027-2032) & (K Dose)
Table 72. Global Non-Adhesive Liquid Embolic Agents Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Medtronic Basic Information, Non-Adhesive Liquid Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 74. Medtronic Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
Table 75. Medtronic Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 76. Medtronic Main Business
Table 77. Medtronic Latest Developments
Table 78. Balt Group Basic Information, Non-Adhesive Liquid Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 79. Balt Group Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
Table 80. Balt Group Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 81. Balt Group Main Business
Table 82. Balt Group Latest Developments
Table 83. Johnson & Johnson Basic Information, Non-Adhesive Liquid Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 84. Johnson & Johnson Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
Table 85. Johnson & Johnson Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Latest Developments
Table 88. Meril Life Basic Information, Non-Adhesive Liquid Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 89. Meril Life Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
Table 90. Meril Life Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 91. Meril Life Main Business
Table 92. Meril Life Latest Developments
Table 93. BlackSwan Vascular Basic Information, Non-Adhesive Liquid Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 94. BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
Table 95. BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 96. BlackSwan Vascular Main Business
Table 97. BlackSwan Vascular Latest Developments
Table 98. Success Bio-Tech Basic Information, Non-Adhesive Liquid Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 99. Success Bio-Tech Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
Table 100. Success Bio-Tech Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 101. Success Bio-Tech Main Business
Table 102. Success Bio-Tech Latest Developments
Table 1. Non-Adhesive Liquid Embolic Agents Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Non-Adhesive Liquid Embolic Agents Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of EVOH-Based
Table 4. Major Players of Diluted Cyanoacrylate
Table 5. Major Players of Others
Table 6. Global Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026) & (K Dose)
Table 7. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2021-2026)
Table 8. Global Non-Adhesive Liquid Embolic Agents Revenue by Type (2021-2026) & ($ million)
Table 9. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Type (2021-2026)
Table 10. Global Non-Adhesive Liquid Embolic Agents Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Global Non-Adhesive Liquid Embolic Agents Sale by Application (2021-2026) & (K Dose)
Table 12. Global Non-Adhesive Liquid Embolic Agents Sale Market Share by Application (2021-2026)
Table 13. Global Non-Adhesive Liquid Embolic Agents Revenue by Application (2021-2026) & ($ million)
Table 14. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Application (2021-2026)
Table 15. Global Non-Adhesive Liquid Embolic Agents Sale Price by Application (2021-2026) & (US$/Dose)
Table 16. Global Non-Adhesive Liquid Embolic Agents Sales by Company (2021-2026) & (K Dose)
Table 17. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Company (2021-2026)
Table 18. Global Non-Adhesive Liquid Embolic Agents Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Company (2021-2026)
Table 20. Global Non-Adhesive Liquid Embolic Agents Sale Price by Company (2021-2026) & (US$/Dose)
Table 21. Key Manufacturers Non-Adhesive Liquid Embolic Agents Producing Area Distribution and Sales Area
Table 22. Players Non-Adhesive Liquid Embolic Agents Products Offered
Table 23. Non-Adhesive Liquid Embolic Agents Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Non-Adhesive Liquid Embolic Agents Sales by Geographic Region (2021-2026) & (K Dose)
Table 27. Global Non-Adhesive Liquid Embolic Agents Sales Market Share Geographic Region (2021-2026)
Table 28. Global Non-Adhesive Liquid Embolic Agents Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Non-Adhesive Liquid Embolic Agents Sales by Country/Region (2021-2026) & (K Dose)
Table 31. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Country/Region (2021-2026)
Table 32. Global Non-Adhesive Liquid Embolic Agents Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026) & (K Dose)
Table 35. Americas Non-Adhesive Liquid Embolic Agents Sales Market Share by Country (2021-2026)
Table 36. Americas Non-Adhesive Liquid Embolic Agents Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026) & (K Dose)
Table 38. Americas Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026) & (K Dose)
Table 39. APAC Non-Adhesive Liquid Embolic Agents Sales by Region (2021-2026) & (K Dose)
Table 40. APAC Non-Adhesive Liquid Embolic Agents Sales Market Share by Region (2021-2026)
Table 41. APAC Non-Adhesive Liquid Embolic Agents Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026) & (K Dose)
Table 43. APAC Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026) & (K Dose)
Table 44. Europe Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026) & (K Dose)
Table 45. Europe Non-Adhesive Liquid Embolic Agents Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026) & (K Dose)
Table 47. Europe Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026) & (K Dose)
Table 48. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026) & (K Dose)
Table 49. Middle East & Africa Non-Adhesive Liquid Embolic Agents Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026) & (K Dose)
Table 51. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026) & (K Dose)
Table 52. Key Market Drivers & Growth Opportunities of Non-Adhesive Liquid Embolic Agents
Table 53. Key Market Challenges & Risks of Non-Adhesive Liquid Embolic Agents
Table 54. Key Industry Trends of Non-Adhesive Liquid Embolic Agents
Table 55. Non-Adhesive Liquid Embolic Agents Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Non-Adhesive Liquid Embolic Agents Distributors List
Table 58. Non-Adhesive Liquid Embolic Agents Customer List
Table 59. Global Non-Adhesive Liquid Embolic Agents Sales Forecast by Region (2027-2032) & (K Dose)
Table 60. Global Non-Adhesive Liquid Embolic Agents Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Non-Adhesive Liquid Embolic Agents Sales Forecast by Country (2027-2032) & (K Dose)
Table 62. Americas Non-Adhesive Liquid Embolic Agents Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Non-Adhesive Liquid Embolic Agents Sales Forecast by Region (2027-2032) & (K Dose)
Table 64. APAC Non-Adhesive Liquid Embolic Agents Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Non-Adhesive Liquid Embolic Agents Sales Forecast by Country (2027-2032) & (K Dose)
Table 66. Europe Non-Adhesive Liquid Embolic Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales Forecast by Country (2027-2032) & (K Dose)
Table 68. Middle East & Africa Non-Adhesive Liquid Embolic Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Non-Adhesive Liquid Embolic Agents Sales Forecast by Type (2027-2032) & (K Dose)
Table 70. Global Non-Adhesive Liquid Embolic Agents Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Non-Adhesive Liquid Embolic Agents Sales Forecast by Application (2027-2032) & (K Dose)
Table 72. Global Non-Adhesive Liquid Embolic Agents Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Medtronic Basic Information, Non-Adhesive Liquid Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 74. Medtronic Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
Table 75. Medtronic Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 76. Medtronic Main Business
Table 77. Medtronic Latest Developments
Table 78. Balt Group Basic Information, Non-Adhesive Liquid Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 79. Balt Group Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
Table 80. Balt Group Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 81. Balt Group Main Business
Table 82. Balt Group Latest Developments
Table 83. Johnson & Johnson Basic Information, Non-Adhesive Liquid Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 84. Johnson & Johnson Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
Table 85. Johnson & Johnson Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Latest Developments
Table 88. Meril Life Basic Information, Non-Adhesive Liquid Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 89. Meril Life Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
Table 90. Meril Life Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 91. Meril Life Main Business
Table 92. Meril Life Latest Developments
Table 93. BlackSwan Vascular Basic Information, Non-Adhesive Liquid Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 94. BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
Table 95. BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 96. BlackSwan Vascular Main Business
Table 97. BlackSwan Vascular Latest Developments
Table 98. Success Bio-Tech Basic Information, Non-Adhesive Liquid Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 99. Success Bio-Tech Non-Adhesive Liquid Embolic Agents Product Portfolios and Specifications
Table 100. Success Bio-Tech Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 101. Success Bio-Tech Main Business
Table 102. Success Bio-Tech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Non-Adhesive Liquid Embolic Agents
Figure 2. Non-Adhesive Liquid Embolic Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-Adhesive Liquid Embolic Agents Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Non-Adhesive Liquid Embolic Agents Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Non-Adhesive Liquid Embolic Agents Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Non-Adhesive Liquid Embolic Agents Sales Market Share by Country/Region (2025)
Figure 10. Non-Adhesive Liquid Embolic Agents Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of EVOH-Based
Figure 12. Product Picture of Diluted Cyanoacrylate
Figure 13. Product Picture of Others
Figure 14. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Type in 2026
Figure 15. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Type (2021-2026)
Figure 16. Non-Adhesive Liquid Embolic Agents Consumed in Brain Arterio-Venous Malformations (bAVM)
Figure 17. Global Non-Adhesive Liquid Embolic Agents Market: Brain Arterio-Venous Malformations (bAVM) (2021-2026) & (K Dose)
Figure 18. Non-Adhesive Liquid Embolic Agents Consumed in Tumor Embolization
Figure 19. Global Non-Adhesive Liquid Embolic Agents Market: Tumor Embolization (2021-2026) & (K Dose)
Figure 20. Non-Adhesive Liquid Embolic Agents Consumed in Others
Figure 21. Global Non-Adhesive Liquid Embolic Agents Market: Others (2021-2026) & (K Dose)
Figure 22. Global Non-Adhesive Liquid Embolic Agents Sale Market Share by Application (2025)
Figure 23. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Application in 2026
Figure 24. Non-Adhesive Liquid Embolic Agents Sales by Company in 2026 (K Dose)
Figure 25. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Company in 2026
Figure 26. Non-Adhesive Liquid Embolic Agents Revenue by Company in 2026 ($ millions)
Figure 27. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Company in 2026
Figure 28. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Non-Adhesive Liquid Embolic Agents Sales 2021-2026 (K Dose)
Figure 31. Americas Non-Adhesive Liquid Embolic Agents Revenue 2021-2026 ($ millions)
Figure 32. APAC Non-Adhesive Liquid Embolic Agents Sales 2021-2026 (K Dose)
Figure 33. APAC Non-Adhesive Liquid Embolic Agents Revenue 2021-2026 ($ millions)
Figure 34. Europe Non-Adhesive Liquid Embolic Agents Sales 2021-2026 (K Dose)
Figure 35. Europe Non-Adhesive Liquid Embolic Agents Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales 2021-2026 (K Dose)
Figure 37. Middle East & Africa Non-Adhesive Liquid Embolic Agents Revenue 2021-2026 ($ millions)
Figure 38. Americas Non-Adhesive Liquid Embolic Agents Sales Market Share by Country in 2026
Figure 39. Americas Non-Adhesive Liquid Embolic Agents Revenue Market Share by Country (2021-2026)
Figure 40. Americas Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2021-2026)
Figure 41. Americas Non-Adhesive Liquid Embolic Agents Sales Market Share by Application (2021-2026)
Figure 42. United States Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Non-Adhesive Liquid Embolic Agents Sales Market Share by Region in 2026
Figure 47. APAC Non-Adhesive Liquid Embolic Agents Revenue Market Share by Region (2021-2026)
Figure 48. APAC Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2021-2026)
Figure 49. APAC Non-Adhesive Liquid Embolic Agents Sales Market Share by Application (2021-2026)
Figure 50. China Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 54. India Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Non-Adhesive Liquid Embolic Agents Sales Market Share by Country in 2026
Figure 58. Europe Non-Adhesive Liquid Embolic Agents Revenue Market Share by Country (2021-2026)
Figure 59. Europe Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2021-2026)
Figure 60. Europe Non-Adhesive Liquid Embolic Agents Sales Market Share by Application (2021-2026)
Figure 61. Germany Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 62. France Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales Market Share by Application (2021-2026)
Figure 69. Egypt Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Non-Adhesive Liquid Embolic Agents in 2026
Figure 75. Manufacturing Process Analysis of Non-Adhesive Liquid Embolic Agents
Figure 76. Industry Chain Structure of Non-Adhesive Liquid Embolic Agents
Figure 77. Channels of Distribution
Figure 78. Global Non-Adhesive Liquid Embolic Agents Sales Market Forecast by Region (2027-2032)
Figure 79. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Non-Adhesive Liquid Embolic Agents Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Non-Adhesive Liquid Embolic Agents Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Non-Adhesive Liquid Embolic Agents
Figure 2. Non-Adhesive Liquid Embolic Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-Adhesive Liquid Embolic Agents Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Non-Adhesive Liquid Embolic Agents Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Non-Adhesive Liquid Embolic Agents Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Non-Adhesive Liquid Embolic Agents Sales Market Share by Country/Region (2025)
Figure 10. Non-Adhesive Liquid Embolic Agents Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of EVOH-Based
Figure 12. Product Picture of Diluted Cyanoacrylate
Figure 13. Product Picture of Others
Figure 14. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Type in 2026
Figure 15. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Type (2021-2026)
Figure 16. Non-Adhesive Liquid Embolic Agents Consumed in Brain Arterio-Venous Malformations (bAVM)
Figure 17. Global Non-Adhesive Liquid Embolic Agents Market: Brain Arterio-Venous Malformations (bAVM) (2021-2026) & (K Dose)
Figure 18. Non-Adhesive Liquid Embolic Agents Consumed in Tumor Embolization
Figure 19. Global Non-Adhesive Liquid Embolic Agents Market: Tumor Embolization (2021-2026) & (K Dose)
Figure 20. Non-Adhesive Liquid Embolic Agents Consumed in Others
Figure 21. Global Non-Adhesive Liquid Embolic Agents Market: Others (2021-2026) & (K Dose)
Figure 22. Global Non-Adhesive Liquid Embolic Agents Sale Market Share by Application (2025)
Figure 23. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Application in 2026
Figure 24. Non-Adhesive Liquid Embolic Agents Sales by Company in 2026 (K Dose)
Figure 25. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Company in 2026
Figure 26. Non-Adhesive Liquid Embolic Agents Revenue by Company in 2026 ($ millions)
Figure 27. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Company in 2026
Figure 28. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Non-Adhesive Liquid Embolic Agents Sales 2021-2026 (K Dose)
Figure 31. Americas Non-Adhesive Liquid Embolic Agents Revenue 2021-2026 ($ millions)
Figure 32. APAC Non-Adhesive Liquid Embolic Agents Sales 2021-2026 (K Dose)
Figure 33. APAC Non-Adhesive Liquid Embolic Agents Revenue 2021-2026 ($ millions)
Figure 34. Europe Non-Adhesive Liquid Embolic Agents Sales 2021-2026 (K Dose)
Figure 35. Europe Non-Adhesive Liquid Embolic Agents Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales 2021-2026 (K Dose)
Figure 37. Middle East & Africa Non-Adhesive Liquid Embolic Agents Revenue 2021-2026 ($ millions)
Figure 38. Americas Non-Adhesive Liquid Embolic Agents Sales Market Share by Country in 2026
Figure 39. Americas Non-Adhesive Liquid Embolic Agents Revenue Market Share by Country (2021-2026)
Figure 40. Americas Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2021-2026)
Figure 41. Americas Non-Adhesive Liquid Embolic Agents Sales Market Share by Application (2021-2026)
Figure 42. United States Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Non-Adhesive Liquid Embolic Agents Sales Market Share by Region in 2026
Figure 47. APAC Non-Adhesive Liquid Embolic Agents Revenue Market Share by Region (2021-2026)
Figure 48. APAC Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2021-2026)
Figure 49. APAC Non-Adhesive Liquid Embolic Agents Sales Market Share by Application (2021-2026)
Figure 50. China Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 54. India Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Non-Adhesive Liquid Embolic Agents Sales Market Share by Country in 2026
Figure 58. Europe Non-Adhesive Liquid Embolic Agents Revenue Market Share by Country (2021-2026)
Figure 59. Europe Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2021-2026)
Figure 60. Europe Non-Adhesive Liquid Embolic Agents Sales Market Share by Application (2021-2026)
Figure 61. Germany Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 62. France Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales Market Share by Application (2021-2026)
Figure 69. Egypt Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Non-Adhesive Liquid Embolic Agents Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Non-Adhesive Liquid Embolic Agents in 2026
Figure 75. Manufacturing Process Analysis of Non-Adhesive Liquid Embolic Agents
Figure 76. Industry Chain Structure of Non-Adhesive Liquid Embolic Agents
Figure 77. Channels of Distribution
Figure 78. Global Non-Adhesive Liquid Embolic Agents Sales Market Forecast by Region (2027-2032)
Figure 79. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Non-Adhesive Liquid Embolic Agents Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Non-Adhesive Liquid Embolic Agents Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share Forecast by Application (2027-2032)
